Precision Medicine of Diabetes Program in China - Trial NCT06320600
Access comprehensive clinical trial information for NCT06320600 through Pure Global AI's free database. This phase not specified trial is sponsored by Second Xiangya Hospital of Central South University and is currently Recruiting. The study focuses on Diabetes. Target enrollment is 120000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Second Xiangya Hospital of Central South University
Timeline & Enrollment
N/A
Jul 01, 2023
Dec 01, 2028
Primary Outcome
The currency analysis of diabetes classification
Summary
The prevalence of diabetes has been increasing year by year. According to the International
 Diabetes Federation (IDF) statistics in 2021, the global number of people with diabetes has
 reached 537 million. The patient population is large and heterogeneous, and precise diagnosis
 and treatment of diabetes patients have been a focus of attention. The objective of this
 study is to clarify the current status of precision classification and diagnosis of diabetes
 patients through retrospective and prospective cohort studies, and to establish a model for
 precision classification and diagnosis of diabetes, improving the accuracy of diabetes
 classification and diagnosis; based on big data of precision medicine for diabetes patients
 and follow-up cohorts, to establish precise diagnostic, therapeutic, and predictive methods
 for diabetes; and through multi-omics data analysis, to explore the potential pathogenesis of
 diabetes, explaining the heterogeneity of patients, and guiding individualized treatment for
 patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06320600
Non-Device Trial